Opioid Dose Trajectories & 1-Year Outcomes
Long-term risks and benefits of opioid dose changes should be considered by clinicians and patients, authors conclude, based on a retrospective cohort study showing both
Michael Posey
October 6, 2022
Long-term risks and benefits of opioid dose changes should be considered by clinicians and patients, authors conclude, based on a retrospective cohort study showing both
Compared with placebo, intravenous immune globulin (IVIG) significantly improved symptoms in patients with active dermatomyositis, researchers report, but was associated with adverse events, including thromboembolism.
Compared with standard opioid prescribing in 193 patients after arthroscopic knee or shoulder surgery, a multimodal opioid-sparing postoperative pain management protocol significantly reduced postoperative opioid
Studies of deprescribing interventions can be improved through steps as simple as “clearly defining clinically meaningful medication outcomes (e.g., number of chronic medications, dose reductions),
Assessing microvascular, cardiovascular, and mortality outcomes when any 1 of 4 antidiabetic agents was added to metformin therapy, the GRADE Study Research Group identified possible
Used for controlling systemic lupus erythematosus (SLE) flares, hydroxychloroquine has reduced efficacy when doses are limited to 5 mg/kg per day, as recommended in ophthalmology